HLTH Stock Overview
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 0/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
My Notes
NewNotes are coming soon
Cue Health Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$2.49 |
| 52 Week High | US$11.90 |
| 52 Week Low | US$1.63 |
| Beta | 0 |
| 1 Month Change | 16.90% |
| 3 Month Change | -34.47% |
| 1 Year Change | -71.18% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -87.55% |
Recent News & Updates
Recent updates
Cue Health Inc. (NASDAQ:HLTH) Analysts Just Trimmed Their Revenue Forecasts By 24%
Nov 18
Here's Why We're Not Too Worried About Cue Health's (NASDAQ:HLTH) Cash Burn Situation
Oct 30Cue Health applies for FDA emergency use nod for its flu & COVID-19 molecular test
Oct 04Cue Health appoints chief medical oficer
Sep 08Cue Health COVID-19 at-home, test-to-treat service launches nationwide
Aug 29Cue Health Non-GAAP EPS of -$0.37 beats by $0.09, revenue of $87.7M beats by $34.8M
Aug 10Cue Health's (NASDAQ:HLTH) Solid Profits Have Weak Fundamentals
May 18Cue Health: Significant Growth Potential Looking Beyond The Pandemic
Jan 10We're Interested To See How Cue Health (NASDAQ:HLTH) Uses Its Cash Hoard To Grow
Dec 24Cue Health IPO: More Than COVID Testing
Oct 01Shareholder Returns
| HLTH | US Medical Equipment | US Market | |
|---|---|---|---|
| 7D | 5.1% | 2.5% | 1.7% |
| 1Y | -71.2% | -10.2% | -9.1% |
Return vs Industry: HLTH underperformed the US Medical Equipment industry which returned -12.8% over the past year.
Return vs Market: HLTH underperformed the US Market which returned -12.5% over the past year.
Price Volatility
| HLTH volatility | |
|---|---|
| HLTH Average Weekly Movement | 14.3% |
| Medical Equipment Industry Average Movement | 8.6% |
| Market Average Movement | 6.8% |
| 10% most volatile stocks in US Market | 17.5% |
| 10% least volatile stocks in US Market | 2.8% |
Stable Share Price: HLTH is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 14% a week.
Volatility Over Time: HLTH's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of US stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2010 | 1,585 | Ayub Khattak | https://www.cuehealth.com |
Cue Health Inc., a healthcare technology company, designs and develops diagnostic platform for diagnostic tests for individuals, enterprises, healthcare providers and payors, and public health agencies. The company offers Cue Integrated Care platform comprising hardware and software components, such as Cue Health Monitoring System consisting of Cue Reader, a portable and reusable reader, Cue Cartridge, a single-use test cartridge, and Cue Wand, a sample collection wand; Cue Data and Innovation Layer, a solution with cloud-based data and analytics capability; Cue Virtual Care Delivery Apps, which include Cue Health App and Cue Enterprise Dashboard; and Cue Ecosystem Integrations and Apps, a solution that allows integrations with third-party applications and sensors. It also provides COVID-19 testing kits for the Cue Health Monitoring System The company was formerly known as Cue Inc and changed its name to Cue Health Inc. in December 2017.
Cue Health Inc. Fundamentals Summary
| HLTH fundamental statistics | |
|---|---|
| Market Cap | US$372.09m |
| Earnings (TTM) | -US$137.96m |
| Revenue (TTM) | US$529.21m |
0.7x
P/S Ratio-2.7x
P/E RatioIs HLTH overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HLTH income statement (TTM) | |
|---|---|
| Revenue | US$529.21m |
| Cost of Revenue | US$384.82m |
| Gross Profit | US$144.39m |
| Other Expenses | US$282.35m |
| Earnings | -US$137.96m |
Last Reported Earnings
Sep 30, 2022
Next Earnings Date
n/a
| Earnings per share (EPS) | -0.92 |
| Gross Margin | 27.28% |
| Net Profit Margin | -26.07% |
| Debt/Equity Ratio | 0% |
How did HLTH perform over the long term?
See historical performance and comparison